Previous 10 | Next 10 |
Gainers: Lianluo Smart (LLIT) +101%, Sundial Growers (SNDL) +51%, Monopar Therapeutics (MNPR) +38%, Regional Health Properties (RHE) +20%, Conversion Labs (CVLB) +18%.Losers: Vir Biotechnology (VIR) -31%, Zymeworks ZYME -25%, American Well (AMWL) -...
Helius Medical Technologies (HSDT) -17%.Avinger (AVGR) -12%.Cango (CANG) -11%.OncoCyte (OCX) -10%.Obalon Therapeutics (OBLN) -10%.Dolphin Entertainment (DLPN) -9%.Surgalign Holdings (SRGA) -8% after pricing equity offering at $1.50.Vertex Energy (VTNR) -7%.Atossa Therapeutics (ATOS)...
Surgalign (SRGA) has priced its public offering of 25M common shares at $1.50/share, for gross proceeds of ~$37.5M.Underwriters' over-allotment is an additional 3.75M shares. Net proceeds will be used for general corporate purposes, working capital, and the financing of future acquisitions.Cl...
DEERFIELD, Ill., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA) (“Surgalign”), a global pure-play spine company focused on advancing the science of spine care by delivering innovative solutions, today announced the pricing of an underwritten public o...
Surgalign ([[SRGA]] +1.5%) commences the commercial launch and the completion of the first surgery of ViBone Moldable, the newest orthobiologics solution of Surgalign’s bone graft portfolio to support spinal fusion, which currently include ViBone and other advanced bone graft...
DEERFIELD, Ill., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes, today announced the commercial launch and th...
DEERFIELD, Ill., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes, today announced that the management team wil...
Company is working off a solid base and balance sheet is clean. The technicals are ultra oversold especially on the long-term chart. The runway for growth in international markets is large. Innovation and more acquisitions expected to really deliver value to patients over time...
DEERFIELD, Ill., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a leading global pure-play spine company focused on advancing spine surgery and improving patient outcomes, today announced that the management team will participate in the Piper Sandler 32nd Annual ...
DEERFIELD, Ill., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes, today announced the appointment of Paul Lewi...